BION:SW BB Biotech AG

CHF 42.70 0.00 0
Icon

BB Biotech AG (BION:SW) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | SW
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CHF 42.70

0.00 (0.00)%

CHF 2.34B

0.05M

N/A

N/A

Icon

BION:SW

BB Biotech AG (CHF)
COMMON STOCK | SW
CHF 42.70
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CHF 2.34B

N/A

CHF 42.70

BB Biotech AG (BION:SW) Stock Forecast

N/A

Based on the BB Biotech AG stock forecast from 0 analysts, the average analyst target price for BB Biotech AG is not available over the next 12 months. BB Biotech AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BB Biotech AG is Bullish , which is based on 7 positive signals and 2 negative signals. At the last closing, BB Biotech AG’s stock price was CHF 42.70. BB Biotech AG’s stock price has changed by -1.04% over the past week, -10.48% over the past month and -14.51% over the last year.

No recent analyst target price found for BB Biotech AG
No recent average analyst rating found for BB Biotech AG

Company Overview BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fun...Read More

Seestrasse 16, Kusnacht, Switzerland, 8700

10

December

CHF

Switzerland

Adjusted Closing Price for BB Biotech AG (BION:SW)

Loading...

Unadjusted Closing Price for BB Biotech AG (BION:SW)

Loading...

Share Trading Volume for BB Biotech AG Shares

Loading...

Compare Performance of BB Biotech AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BION:SW

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BB Biotech AG (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BSLN:SW
Basilea Pharmaceutica AG 0.00 (0.00%) CHF0.49B 47.03 23.85

ETFs Containing BION

Symbol Name BION's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BB Biotech AG (BION:SW) Stock

Stock Target Advisor's fundamental analysis for BB Biotech AG's stock is Bullish .

BION:SW stock's dividend yield is 4.42%. Our analysis grades BION:SW stock's dividend yield at A+. This means that BION:SW stock's dividend yield is above 100% of the stocks in the Biotechnology sector in the SW exchange. Based on this BION:SW may be a good dividend stock for its sector.

Unfortunately we do not have enough data on BION:SW's stock to indicate what its average analyst target is.

BION:SW stock's Price/Earning ratio is 4.49. Our analysis grades BION:SW stock's Price / Earning ratio at B-. This means that BION:SW stock's Price/Earning ratio is above 20% of the stocks in the Biotechnology sector in the SW exchange. Based on this BION:SW may be undervalued for its sector.

The last closing price of BION:SW's stock was CHF 42.70.

The most recent market capitalization for BION:SW is CHF 2.34B.

Unfortunately we do not have enough analyst data on BION:SW's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BB Biotech AG's stock.

As per our most recent records BB Biotech AG has 10 Employees.

BB Biotech AG's registered address is Seestrasse 16, Kusnacht, Switzerland, 8700. You can get more information about it from BB Biotech AG's website at https://www.bbbiotech.ch/en/bb-biotech/.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...